Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway

Cell Death and Disease

Volumn 6, Issue 5, 2015, Pages

  Yao, D D ^a   Yang, L ^a   Wang, Y ^b   Liu, C ^c   Wei, Y J ^a   Jia, X B ^a   Yin, W ^d   Shu, L ^a  

^a Jiangsu Province Academy of Chinese Medicine   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GENIPOSIDE; GLUCOSE; JANUS KINASE 2; N BENZYL 1,2,3,4,8,9 HEXAHYDRO 6 (4 HYDROXYBENZYL) 8 (1 NAPHTHYLMETHYL) 4,7 DIOXO 2H PYRAZINO[1,2 A]PYRIMIDINE 1(6H) CARBOXAMIDE; PROTEIN KINASE B; STAT3 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; IRIDOID; MESSENGER RNA; TCF7L2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DB/DB MOUSE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EXOCRINE CELL; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LIPID DIET; MALE; MIN6 CELL LINE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; REGENERATION; TRANSGENIC MOUSE;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; IRIDOIDS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REGENERATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84957309153     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.107     Document Type: Article

References (51)

1. Robertson RP. Type II diabetes, glucose "non-sense", and islet desensitization. Diabetes 1989;38:1501-1505.
2. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-1812.
3. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004;429:41-46.
4. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotechnol 2005;23:857-861.
5. Welters HJ, Kulkarni RN. Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol Metab 2008;19:349-355.
6. Jin T, Liu L. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol Endocrinol 2008;22:2383-2392.
7. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 2007;104:6247-6252.
8. Figeac F, Uzan B, Faro M, Chelali N, Portha B, Movassat J. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats. Am J Physiol Endocrinol Metab 2010;298:E245-E256.
9. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009;18:2388-2399.
10. Shu L, Zien K, Gutjahr G, Oberholzer J, Pattou F, Kerr-Conte J et al. TCF7L2 promotes beta cell regeneration in human and mouse pancreas. Diabetologia 2012;55:3296-3307.
11. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008;57:645-653.
12. da Silva Xavier G, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 2009;58:894-905.
13. da Silva Xavier G, Mondragon A, Sun G, Chen L, McGinty JA, French PM et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 2012;55:2667-2676.
14. Takamoto I, Kubota N, Nakaya K, Kumagai K, Hashimoto S, Kubota T et al. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Diabetologia 2014;57:542-553.
15. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005;280:1457-1464.
16. Koo HJ, Song YS, Kim HJ, Lee YH, Hong SM, Kim SJ et al. Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 2004;495:201-208.
17. Pham TQ, Cormier F, Farnworth E, Tong VH, Van Calsteren MR. Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen. J Agric Food Chem 2000;48:1455-1461.
18. Kimura Y, Okuda H, Arichi S. Effects of geniposide isolated from Gardenia jasminoides on metabolic alterations in high sugar diet-fed rats. Chem Pharm Bull (Tokyo) 1982;30:4444-4447.
19. Wu SY, Wang GF, Liu ZQ, Rao JJ, Lu L, Xu W et al. Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacol Sin 2009;30:202-208.
20. Guo LX, Xia ZN, Gao X, Yin F, Liu JH. Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells. Acta Pharmacol Sin 2012;33:237-241.
21. Liu J, Yin F, Xiao H, Guo L, Gao X. Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced beta-cell apoptosis. Toxicol In Vitro 2012;26:1093-1097.
22. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005;54(Suppl 2):S108-S113.
23. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA et al. Glucoseinduced beta-cell production of interleukin-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002;110:851-860.
24. Koole C, Pabreja K, Savage EE, Wootten D, Furness SG, Miller LJ et al. Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function. Biochem Soc Trans 2013;41:172-179.
25. Xu G, Kaneto H, Laybutt DR, Duvivier-Kali VF, Trivedi N, Suzuma K et al. Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 2007;56:1551-1558.
26. Zhou J, Livak MF, Bernier M, Muller DC, Carlson OD, Elahi D et al. Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. Am J Physiol Endocrinol Metab 2007;293:E538-E547.
27. Zhao Z, Choi J, Zhao C, Ma ZA. FTY720 normalizes hyperglycemia by stimulating beta-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57 (KIP2). J Biol Chem 2012;287:5562-5573.
28. Han SJ, Choi SE, Yi SA, Lee SJ, Kim HJ, Kim DJ et al. β-Cell-protective effect of 2-aminobicyclo-(2, 2, 1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice. J Endocrinol 2012;212:307-315.
29. Do GM, Jung UJ, Park HJ, Kwon EY, Jeon SM, McGregor RA et al. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol Nutr Food Res 2012;56:1282-1291.
30. Hao E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I, Monosov EZ et al. Beta-cell differentiation from nonendocrine epithelial cells of the adult human pancreas. Nat Med 2006;12:310-316.
31. Uzan B, Figeac F, Portha B, Movassat J. Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and differentiation. PLoS One 2009;4:e4734.
32. Gradwohl G, Dierich A, LeMeur M, Guillemot F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000;97:1607-1611.
33. Lee JH, Jo J, Hardikar AA, Periwal V, Rane SG. Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass. PLoS One 2010;5:e8653.
34. Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L et al. TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet 2014;23:6419-6431.
35. Baeyens L, Bonne S, German MS, Ravassard P, Heimberg H, Bouwens L. Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway. Cell Death Differ 2006;13:1892-1899.
36. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110.
37. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A. Beta-cell growth and regeneration: replication is only part of the story. Diabetes 2010;59:2340-2348.
38. Gianani R. Beta cell regeneration in human pancreas. Semin Immunopathol 2011;33:23-27.
39. Desgraz R, Bonal C, Herrera PL. β-cell regeneration: the pancreatic intrinsic faculty. Trends Endocrinol Metab 2011;22:34-43.
40. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007;70:461-477.
41. Marles R, Durst T, Kobaisy M, Soucy-Breau C, Abou-Zaid M, Arnason JT et al. Pharmacokinetics, metabolism and toxicity of the plant-derived photoxin alpha-terthienyl. Pharmacol Toxicol 1995;77:164-168.
42. Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 2008;283:8723-8735.
43. Hughes TE. Emerging therapies for metabolic diseases-the focus is on diabetes and obesity. Curr Opin Chem Biol 2009;13:332-337.
44. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007;117:2155-2163.
45. Boj SF, van Es JH, Huch M, Li VS, Jose A, Hatzis P et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012;151:1595-1607.
46. McCarthy MI, Rorsman P, Gloyn AL. TCF7L2 and diabetes: a tale of two tissues, and of two species. Cell Metab 2013;17:157-159.
47. Suarez-Pinzon WL, Lakey JR, Brand SJ, Rabinovitch A. Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet {beta}-cells from pancreatic duct cells and an increase in functional {beta}-cell mass. J Clin Endocrinol Metab 2005;90:3401-3409.
48. Shin JA, Hong OK, Lee HJ, Jeon SY, Kim JW, Lee SH et al. Transforming growth factor-beta induces epithelial to mesenchymal transition and suppresses the proliferation and transdifferentiation of cultured human pancreatic duct cells. J Cell Biochem 2011;112:179-188.
49. Rafaeloff R, Pittenger GL, Barlow SW, Qin XF, Yan B, Rosenberg L et al. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997;99:2100-2109.
50. Liu YC, Lai WC, Chuang KA, Shen YJ, Hu WS, Ho CH et al. Blockade of JAK2 activity suppressed accumulation of beta-catenin in leukemic cells. J Cell Biochem 2010;111:402-411.
51. Yan S, Zhou C, Zhang W, Zhang G, Zhao X, Yang S et al. beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett 2008;271:85-97.